Table 2.
Demographic and clinical characteristics of the patient and control groups who were used for the real-time polymerase chain reaction analysis undertaken to determine the differential expression of the microRNA hsa-miR-21-5p in patients with intracerebral haemorrhage.
| Patient group n = 31 | Control group n = 22 | |
|---|---|---|
| Age, years | 64.68 ± 6.04 | 64.45 ± 5.67 |
| Sex, male | 19 (61.3) | 12 (54.5) |
| Systolic blood pressure at admission, mmHg | 155.52 ± 21.18 | 144.27 ± 21.46 |
| Diastolic blood pressure at admission, mmHg | 107.61 ± 21.15 | 103.23 ± 21.81 |
| White blood cell count, ×109/l | 9.04 ± 2.95 | 7.58 ± 2.14 |
| Platelet count, ×109/l | 222.26 ± 64.90 | 210.27 ± 46.85 |
| Fasting blood glucose, mmol/l | 7.75 ± 2.70 | 7.74 ± 2.38 |
| Smoking history | 14 (45.2) | 9 (40.9) |
| History of antiplatelet drug use | 13 (41.9) | 7 (31.8) |
| Body mass index, kg/m2 | 24.86 ± 2.91 | 23.93 ± 2.83 |
Data presented as mean ± SD or n of patients (%).
No significant between-group differences (P ≥ 0.05).